The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

Table 4 Comparison of the area under the curve between each scoring system at different follow-up intervals

Period	AUC	95% CI	P-value
6-month
GPS	0.768	0.655-0.882	<0.0001
mGPS	0.734	0.604-0.864	<0.0001
CLIP	0.871	0.779-0.963	<0.0001
JIS	0.837	0.752-0.922	<0.0001
BCLC	0.85	0.773-0.935	<0.0001
TNM	0.84	0.753-0.921	<0.0001
12-month
GPS	0.79	0.699-0.876	<0.0001
mGPS	0.75	0.650-0.855	<0.0001
CLIP	0.88	0.804-0.948	<0.0001
JIS	0.86	0.794-0.924	<0.0001
BCLC	0.88	0.813-0.946	<0.0001
TNM	0.84	0.771-0.918	<0.0001
18-month
GPS	0.78	0.690-0.864	<0.0001
mGPS	0.710	0.690-0.810	<0.0001
CLIP	0.842	0.768-0.916	<0.0001
JIS	0.83	0.753-0.901	<0.0001
BCLC	0.83	0.753-0.905	<0.0001
TNM	0.79	0.699-0.871	<0.0001
24-month
GPS	0.76	0.667-0.848	<0.0001
mGPS	0.7	0.595-0.795	<0.0001
CLIP	0.84	0.770-0.918	<0.0001
JIS	0.8	0.723-0.882	<0.0001
BCLC	0.800	0.719-0.881	<0.0001
TNM	0.76	0.675-0.852	<0.0001

Abbreviations: AUC = are under the receiver operating curve; 95% CI = 95% confidence interval;
GPS = Glasgow Prognostic Score; mGPS = modified Glasgow Prognostic Score;
CLIP = Cancer of the Liver Italian Program; JIS = Japan Integrated Staging score;
BCLC = Barcelona Clinic Liver Cancer; TNM = tumor nodes metastasis classification.

ISSN: 1471-2407